164 related articles for article (PubMed ID: 33259032)
1. Inter- and intraobserver agreement of the quantitative assessment of [
Hughes DJ; Chand G; Goh V; Cook GJR
EJNMMI Res; 2020 Dec; 10(1):145. PubMed ID: 33259032
[TBL] [Abstract][Full Text] [Related]
2. Inter-rater and intra-rater agreement of [
Hughes DJ; Chand G; Johnson J; Bailey D; Adamson K; Goh V; Cook GJR
EJNMMI Res; 2023 May; 13(1):51. PubMed ID: 37256434
[TBL] [Abstract][Full Text] [Related]
3. Early Phase I Study of a
Xing Y; Chand G; Liu C; Cook GJR; O'Doherty J; Zhao L; Wong NCL; Meszaros LK; Ting HH; Zhao J
J Nucl Med; 2019 Sep; 60(9):1213-1220. PubMed ID: 30796165
[TBL] [Abstract][Full Text] [Related]
4. [
Nazir MS; Hughes DJ; Chand G; Adamson K; Johnson J; Bailey D; Gibson V; Ting HH; Lyon AR; Cook GJR;
EJNMMI Res; 2023 May; 13(1):44. PubMed ID: 37195370
[TBL] [Abstract][Full Text] [Related]
5. Preclinical development and characterisation of
Wong NC; Cai Y; Meszaros LK; Biersack HJ; Cook GJ; Ting HH; Mottaghy FM
Am J Nucl Med Mol Imaging; 2021; 11(3):154-166. PubMed ID: 34234994
[TBL] [Abstract][Full Text] [Related]
6. Inter- and intraobserver agreement of programmed death ligand 1 scoring in head and neck squamous cell carcinoma, urothelial carcinoma and breast carcinoma.
Downes MR; Slodkowska E; Katabi N; Jungbluth AA; Xu B
Histopathology; 2020 Jan; 76(2):191-200. PubMed ID: 31243779
[TBL] [Abstract][Full Text] [Related]
7. Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
Gao H; Wu Y; Shi J; Zhang X; Liu T; Hu B; Jia B; Wan Y; Liu Z; Wang F
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203663
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Imaging of Tumor PD-L1 Expression Using [
Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [
Hughes DJ; Chand G; Goh V; Cook GJR
EJNMMI Res; 2021 Oct; 11(1):102. PubMed ID: 34637006
[No Abstract] [Full Text] [Related]
10. Reproducibility of Lobar Perfusion and Ventilation Quantification Using SPECT/CT Segmentation Software in Lung Cancer Patients.
Provost K; Leblond A; Gauthier-Lemire A; Filion É; Bahig H; Lord M
J Nucl Med Technol; 2017 Sep; 45(3):185-192. PubMed ID: 28408698
[TBL] [Abstract][Full Text] [Related]
11. Nanobody-mediated SPECT/CT imaging reveals the spatiotemporal expression of programmed death-ligand 1 in response to a CD8
Ertveldt T; Meulewaeter S; De Vlaeminck Y; Olarte O; Broos K; Van Calenbergh S; Bourgeois S; Deprez J; Heremans Y; Goyvaerts C; Staels W; De Smedt S; Dewitte H; Devoogdt N; Keyaerts M; Verbeke R; Barbé K; Lentacker I; Breckpot K
Theranostics; 2023; 13(15):5483-5500. PubMed ID: 37908728
[No Abstract] [Full Text] [Related]
12. Comparison of
Erber R; Stöhr R; Herlein S; Giedl C; Rieker RJ; Fuchs F; Ficker JH; Hartmann A; Veltrup E; Wirtz RM; Brueckl WM
Anticancer Res; 2017 Dec; 37(12):6771-6778. PubMed ID: 29187455
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Evaluation of Tumoral PD-L1 Using a Novel
Hu B; Ma X; Shi L; Liu T; Li L; Yao M; Li C; Jia B
Mol Pharm; 2024 Apr; 21(4):1977-1986. PubMed ID: 38395797
[TBL] [Abstract][Full Text] [Related]
14. High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma.
Robert ME; Rüschoff J; Jasani B; Graham RP; Badve SS; Rodriguez-Justo M; Kodach LL; Srivastava A; Wang HL; Tang LH; Troncone G; Rojo F; Van Treeck BJ; Pratt J; Shnitsa I; Kumar G; Karasarides M; Anders RA
Mod Pathol; 2023 May; 36(5):100154. PubMed ID: 36925069
[TBL] [Abstract][Full Text] [Related]
15. Assessment of technetium-99m labeled macroaggregated albumin rhinoscintigraphy for the measurement of nasal mucociliary transport rate: intratest, interobserver, and intraobserver reproducibility.
Dostbil Z; Dag Y; Cetinkaya O; Akdag M; Tasdemir B
Scientifica (Cairo); 2014; 2014():982515. PubMed ID: 24741446
[TBL] [Abstract][Full Text] [Related]
16.
Xiao L; Yu S; Xu W; Sun Y; Xin J
Korean J Radiol; 2023 Nov; 24(11):1142-1150. PubMed ID: 37899523
[TBL] [Abstract][Full Text] [Related]
17. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
18. Coregistered ventilation and perfusion SPECT using krypton-81m and Tc-99m-labeled macroaggregated albumin with multislice CT utility for prediction of postoperative lung function in non-small cell lung cancer patients.
Ohno Y; Koyama H; Takenaka D; Nogami M; Kotani Y; Nishimura Y; Yoshimura M; Yoshikawa T; Sugimura K
Acad Radiol; 2007 Jul; 14(7):830-8. PubMed ID: 17574133
[TBL] [Abstract][Full Text] [Related]
19. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
[TBL] [Abstract][Full Text] [Related]
20.
Murad V; Suh M; Choi H; Cheon GJ; Na KJ; Kim YT
BMC Cancer; 2023 Apr; 23(1):381. PubMed ID: 37101187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
